A case of fulminant Goodpasture syndrome following alemtuzumab treatment for multiple sclerosis

被引：0
|
作者：
Lapointe, E. [1 ]
Moghaddam, B. [2 ]
Barclay, K. [1 ]
Neufeld, P. [3 ]
Phelps, R. [4 ,5 ]
Traboulsee, A. [1 ]
机构：
[1] Univ British Columbia, Neurol, Vancouver, BC, Canada
[2] Univ British Columbia, Internal Med, Vancouver, BC, Canada
[3] Univ British Columbia, Nephrol, Vancouver, BC, Canada
[4] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[5] Edinburgh Royal Infirm, Edinburgh, Midlothian, Scotland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1207
引用
收藏
页码：640 / 640
页数：1
相关论文
共 50 条
  • [31] An unforeseen reality: Hemophagocytic lymphohistiocytosis following alemtuzumab treatment for a multiple sclerosis
    Osep, Anka Blagotinsek
    Brecl, Eva
    Skerget, Matevz
    Savsek, Lina
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 228
  • [32] Severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis
    Brannigan, Jamie
    Jones, Joanne L.
    Stacpoole, Sybil R. L.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (05):
  • [33] Acute respiratory distress syndrome following alemtuzumab therapy for relapsing multiple sclerosis
    Yann, Keh
    Jackson, Fran
    Sharaf, Nazar
    Mihalova, Tatiana
    Talbot, Paul
    Rog, David
    Pace, Adrian
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 14 : 1 - +
  • [34] Cytomegalovirus Reactivation During Alemtuzumab Treatment for Multiple Sclerosis: A Case Report
    De Mercanti, Stefania
    Durelli, Luca
    Iudicello, Marco
    Artusi, Carlo Alberto
    Barbero, Pierangelo
    Guerrasio, Angelo
    Clerico, Marinella
    NEUROLOGY, 2016, 86
  • [35] The first reported case of autoimmune hepatitis following alemtuzumab therapy for multiple sclerosis
    Canham, L. J. W.
    Mozayani, B.
    Chelvaratnam, U.
    Przemioslo, R.
    Stevens, J.
    Fry, C.
    Batty, T.
    Inglis, K. E. A.
    Cottrell, D. A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 928 - 929
  • [36] Alopecia totalis following alemtuzumab treatment in relapsing-remitting multiple sclerosis
    Zimmermann, J.
    Buhl, T.
    Mueller, M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 382 - 382
  • [37] Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study
    Kazakou, Paraskevi
    Tzanetakos, Dimitrios
    Vakrakou, Aigli G.
    Tzartos, John S.
    Evangelopoulos, Maria-Eleptheria
    Anagnostouli, Maria
    Stathopoulos, Panos
    Kassi, Georgia N.
    Stefanis, Leonidas
    Kilidireas, Constantinos
    Zapanti, Evangelia
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (06) : 2885 - 2894
  • [38] Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study
    Paraskevi Kazakou
    Dimitrios Tzanetakos
    Aigli G. Vakrakou
    John S. Tzartos
    Μaria-Eleptheria Evangelopoulos
    Maria Anagnostouli
    Panos Stathopoulos
    Georgia N. Kassi
    Leonidas Stefanis
    Constantinos Kilidireas
    Evangelia Zapanti
    Clinical and Experimental Medicine, 2023, 23 : 2885 - 2894
  • [39] Guillain-Barre syndrome after treatment with alemtuzumab in a patient with multiple sclerosis
    Balducci, C.
    Pirro, F.
    Grimoldi, M.
    Cutelle, C.
    Cereda, D.
    Fusco, M. L.
    Frigo, M.
    Cavaletti, G.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 929 - 930
  • [40] A Case of Severe Legionella Pneumonia following the Second Treatment Course of Alemtuzumab Infusion for Relapsing Remitting Multiple Sclerosis
    Spurgeon, Elizabeth
    Abbatemarco, Justin
    Rensel, Mary
    NEUROLOGY, 2018, 90
12345